About Us

The University of Michigan Pancreatic Cancer Center was established in 2012 and is dedicated to the mission of helping improve the lives of patients with pancreatic cancer by expanding the scientific knowledge about the disease.

Leadership

Diane Simeone, MD

Diane M. Simeone, M.D.
Lazar J. Greenfield Professor of Surgery and of Molecular and Integrative Physiology
Director, Multidisciplinary Pancreatic Tumor Program
Director, Translational Oncology Program (TOP)
Director, Pancreatic Cancer Center

Diane M. Simeone, M.D., is the founding director of the University of Michigan Pancreatic Cancer Center. Dr. Simeone is currently the Lazar J. Greenfield Endowed Professor of Surgery and Physiology and Division Chief of HPB and Advanced GI Surgery at the University of Michigan Medical Center. She is the Director of the GI Oncology Program for the University of Michigan Comprehensive Cancer Center and the co-PI of the University of Michigan SPORE Grant in GI Malignancies. Dr. Simeone's principal clinical interests are in the management of solid and cystic pancreatic tumors. She is the Director of the University of Michigan Translational Oncology Program. Professor Simeone has multiple NIH grants investigating the molecular mechanisms important in the development and progression of pancreatic adenocarcinoma and the function of cancer stem cells. She also leads several studies developing biomarkers for the early diagnosis of pancreatic malignancy. She currently serves as an Associate Editor of the journal Gastroenterology and is the past-President of the Society of University Surgeons and the American Pancreatic Association. Dr. Simeone serves on the Scientific Advisory Board for the Pancreatic Cancer Action Network, National Pancreas Foundation, and the NCI Pancreatic Cancer Task Force. Dr. Simeone is a member of the Institute of Medicine.

 

Michelle Anderson, MD, M.Sc.

Michelle A. Anderson, M.D., M.Sc.
Co-Director of the University of Michigan Pancreatic Cancer Center

Michelle A. Anderson, M.D., M.Sc., completed her Internal Medicine residency and Gastroenterology fellowship at the University of Michigan where she trained in advanced endoscopy including endoscopic ultrasound and ERCP.

Following fellowship training, she joined the faculty at Michigan. Dr. Anderson's clinical and research interests focus on diseases of the pancreas and biliary system with a special emphasis on chronic pancreatitis, pancreatic cancer and therapeutic EUS and ERCP as they relate to these diseases.

In 2005, she received a Master of Science degree in Clinical Research and Statistical Analysis from the University of Michigan's School of Public Health. With funding from the NIH, Dr. Anderson combines her clinical and research training to conduct research to identify biomarkers to distinguish pancreatic cancer from chronic pancreatitis. She performs EUS and ERCP in clinical practice as well as in teaching forums both nationally and internationally.

She is an active member of the American Society of Gastrointestinal Endoscopy (ASGE), the American Gastroenterological Association and the American College of Gastroenterology. Dr. Anderson is a Fellow of the ASGE and has served on the ASGE Standards of Practice Committee and the ASGE Institute for Training and Technology for almost 10 years.

 

Max S. Wicha, MD

Max S. Wicha, M.D.
Director, U-M Comprehensive Cancer Center

As founding director of the University of Michigan Comprehensive Cancer Center, Max S. Wicha, M.D., is responsible for coordinating all cancer activities related to research and patient care.

Dr. Wicha also serves as the distinguished professor of oncology, professor of internal medicine and is nationally known for his research in the field of breast oncology, particularly the study of how breast cancer cells grow and metastasize. His lab was part of the team that first discovered stem cells in breast cancer, the first described in any human solid tumor.

Since then, Dr. Wicha has become one of the leading experts on cancer stem cells, with his continued work on breast cancer stem cells. He has also led efforts within the UMCCC to expand these findings into other tumor types. U-M researchers were first to discover stem cells in pancreatic and head and neck cancers and are focusing on cancer stem cells in virtually every cancer type, including colon, lung and thyroid tumors.

Dr. Wicha is also active as a clinician, specializing in the treatment of breast cancer patients. He has served as chairman of the board of the Association of American Cancer Institutes and as past chairman for the National Cancer Institute's Cancer Center Support Review Committee.

Dr. Wicha joined the University of Michigan Medical Center in 1980. From 1984 to 1993, he served as chief in the Division of Hematology/Oncology in the Department of Internal Medicine. Dr. Wicha received his medical degree from Stanford University and trained in internal medicine at the University of Chicago. He then went on to the National Cancer Institute, where he trained in clinical oncology and cancer biology.

Return to top

updated 10.2013

Bookmark and Share

Make a gift to the U-M Comprehensive Cancer Center Pancreatic Cancer Center